The us government has taken a significant step in reclassifying cannabis from a Routine I drug to the fewer stringent Agenda III drug. This historic transfer marks the first time the U.S. governing administration has acknowledged the probable clinical advantages of cannabis. This change opens up new avenues for affected individual entry, study, as … Read More